Friday, November 30, 2012
This Compendium includes a wealth of reports on drugs, biologics and medical devices. The reports included consist of the authority to regulate drug compounding; the law and intellectual property rights of biologics; federal drug discovery and pricing; the FDA’s Safety and Innovation ACT (P.L. 112-114); effects on pharmaceutical innovation and effects of generic brands; infringement and experimental use under the Hatch-Waxman Act. Furthermore, the reauthorization of the Prescription Drug User Fee Act (PDUFA); and how the FDA approves drugs and regulates their safety and effectiveness.
Date of Report: October 17, 2012
Number of Pages: 268
Order Number: C-12010
C-12010.pdf to use the SECURE SHOPPING CART
For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery. Phone orders are preferred and receive priority processing.
at 8:39 AM